Related Experiment Video

Updated: Jul 19, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Improving outcomes in ovarian cancer

Michelle Vaughan, Peter Sykes, Carol Johnson

    The New Zealand Medical Journal
    |September 26, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
    07:59

    Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

    Published on: December 5, 2020

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
    08:26

    Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

    Published on: February 23, 2024

    Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
    07:59

    Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

    Published on: December 5, 2020

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    A Hierarchical Etched Grid for Correlative Chemical Imaging.

    Chemical & biomedical imaging·2026

    Economic burden of human papillomavirus-related cancers in New Zealand.

    BMJ public health·2026

    "It Feels Like Another Thing Cancer Took From Me"- Exploring Cervical Cancer Patients' Experience of Financial Toxicity in Aotearoa, New Zealand.

    Journal of medical imaging and radiation oncology·2026

    'Point-of-Care-Testing is definitely the way to go': primary healthcare professionals in rural Aotearoa New Zealand talk about point-of-care testing for cervical cancer prevention.

    Journal of primary health care·2026

    Opportunities to flip the narrative from burden to action for young women joining the National Cervical Screening Programme in Aotearoa New Zealand: a Kaupapa Māori qualitative exploration of experiences and knowledge of cervical screening for 18-30 year olds.

    Journal of primary health care·2025

    "Mana Motuhake - I am in Charge and Have Control Over my Body": a Cross-Sectional Survey Describing Māori Participants' Experience with HPV Primary Screening in Aotearoa New Zealand.

    Journal of racial and ethnic health disparities·2025

    Publicly funded healthcare, social insurance and justice in Aotearoa New Zealand.

    The New Zealand medical journal·2026

    Drilling a hole to shorten the gap: an Aotearoa New Zealand therapeutic algorithm for status epilepticus in NEUROPA (Madrid, Spain).

    The New Zealand medical journal·2026

    The impact of New Zealand's 2018 methamphetamine policy on residential contamination.

    The New Zealand medical journal·2026

    The Deterioration Early Warning System for aged residential care: a feasibility study with qualitative analysis.

    The New Zealand medical journal·2026

    Hand grip strength and future hospitalisations in Māori and non-Māori New Zealand octogenarians: the LiLACS NZ cohort study.

    The New Zealand medical journal·2026

    Whitia Kia Ora: a culturally responsive model of Bicillin L-A® delivery for people with rheumatic fever in the Waikato region of Aotearoa New Zealand.

    The New Zealand medical journal·2026

    Robotic gastric Roux-en-Y bypass with or without concomitant cholecystectomy: pilot open label randomized trial.

    BJS open·2026

    The Relationship of CD4+, CD8+, and FOXP3+ Tumor-Infiltrating Lymphocytes and Their Ratios With Clinicopathological Parameters and Tumor Budding in Esophageal Squamous Cell Carcinoma.

    International journal of surgical pathology·2026

    Reduced Versus Full Lead-In Apixaban or Rivaroxaban in Acute Venous Thromboembolism: A Systematic Review.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

    FOLFOXIRI Plus Panitumumab for Left-sided RAS-wild-type Metastatic Colorectal Cancer.

    The oncologist·2026

    Nanoparticles for fluorescence-guided breast cancer surgery: advances in in vivo preclinical research.

    Nanomedicine (London, England)·2026

    Clamshell and Hemiclamshell Incisions for Complex Intrathoracic Tumors: A Retrospective Analysis of Indications and Outcomes.

    Thoracic cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us